Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$628M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$608M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$518M |
| 4 |
Intel
INTC
|
+$172M |
| 5 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$122M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$565M |
| 2 |
Amazon
AMZN
|
+$437M |
| 3 |
Microsoft
MSFT
|
+$405M |
| 4 |
NVIDIA
NVDA
|
+$226M |
| 5 |
LyondellBasell Industries
LYB
|
+$224M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.07% |
| 2 | Financials | 5.69% |
| 3 | Healthcare | 5.49% |
| 4 | Consumer Discretionary | 4.41% |
| 5 | Industrials | 3.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3251
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.44B
| $447K | ﹤0.01% |
8,058
-2,043
| -20% | -$118K |
|
3252
Stride
LRN
$3.41B
| $444K | ﹤0.01% |
10,890
+885
| +9% | +$32.8K |
|
3253
PUT
Magnite
MGNI
$2.76B
| $444K | ﹤0.01% |
50,000
| – | – |
|
|
AYLA
3254
DELISTED
Ayala Pharmaceuticals, Inc. Common Stock
AYLA
| $444K | ﹤0.01% |
+407,011
| New | +$930K |
|
|
AHRT
3255
AH Realty Trust
AHRT
$529M
| $443K | ﹤0.01% |
34,552
-34,004
| -50% | -$462K |
|
3256
Deluxe
DLX
$1.18B
| $443K | ﹤0.01% |
20,439
-16,490
| -45% | -$420K |
|
3257
Teekay
TK
$1.01B
| $443K | ﹤0.01% |
153,872
+137,666
| +849% | +$451K |
|
3258
CALL
Illumina
ILMN
$31B
| $442K | ﹤0.01% |
2,467
-7,710
| -76% | -$1.97M |
|
3259
Banc of California
BANC
$3.03B
| $441K | ﹤0.01% |
25,064
-22,878
| -48% | -$417K |
|
3260
Central Garden & Pet Co
CENT
$2.69B
| $441K | ﹤0.01% |
13,001
-5,079
| -28% | -$178K |
|
|
RBCP
3261
DELISTED
RBC Bearings Incorporated 5.00% Series A Mandatory Convertible Preferred Stock
RBCP
| $441K | ﹤0.01% |
4,632
-2,204
| -32% | -$205K |
|
3262
CALL
HDFC Bank
HDB
$123B
| $440K | ﹤0.01% |
+16,000
| New | +$451K |
|
3263
First Interstate BancSystem
FIBK
$3.69B
| $439K | ﹤0.01% |
11,529
+1,936
| +20% | +$69K |
|
3264
Main Street Capital
MAIN
$5.06B
| $439K | ﹤0.01% |
11,386
+11,375
| +103,409% | +$445K |
|
|
RCM
3265
DELISTED
R1 RCM Inc. Common Stock
RCM
| $439K | ﹤0.01% |
20,953
+4,589
| +28% | +$104K |
|
|
HRT
3266
DELISTED
HireRight Holdings Corporation
HRT
| $439K | ﹤0.01% |
30,887
+29,991
| +3,347% | +$467K |
|
|
GDEN
3267
DELISTED
Golden Entertainment
GDEN
| $438K | ﹤0.01% |
11,069
-8,284
| -43% | -$390K |
|
3268
ICU Medical
ICUI
$4.21B
| $438K | ﹤0.01% |
2,656
-25,842
| -91% | -$4.97M |
|
3269
NorthWestern Energy
NWE
$4.23B
| $437K | ﹤0.01% |
7,427
+1,312
| +21% | +$78.1K |
|
3270
Invesco BuyBack Achievers ETF
PKW
$1.72B
| $437K | ﹤0.01% |
5,632
+3,456
| +159% | +$293K |
|
|
TCN
3271
DELISTED
Tricon Residential Inc.
TCN
| $437K | ﹤0.01% |
43,205
-2,545
| -6% | -$32.7K |
|
3272
Ducommun
DCO
$2.7B
| $436K | ﹤0.01% |
10,137
+1,983
| +24% | +$95.1K |
|
3273
V2X
VVX
$2.83B
| $436K | ﹤0.01% |
13,019
-714
| -5% | -$25.3K |
|
3274
CALL
Agios Pharmaceuticals
AGIO
$1.79B
| $435K | ﹤0.01% |
19,600
-10,300
| -34% | -$233K |
|
|
3275
PUT
Agios Pharmaceuticals
AGIO
$1.79B
| $435K | ﹤0.01% |
19,600
-10,400
| -35% | -$235K |
|
Similar funds
Citigroup's Q2 2022 Portfolio in Review
As of Q2 2022, Citigroup held 6,955 positions worth $134B, down 18% from $165B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Citigroup's Q2 2022 filing shows 507 new, 2,096 increased, 2,889 reduced and 579 closed positions. Its largest new stake was State Street SPDR MarketAxess Investment Grade 400 Corporate Bond ETF: 250,000 shares worth $24.7M. The largest sale was iShares Russell 2000 ETF, an estimated $565M.
By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 12% a quarter earlier, followed by Financials and Healthcare.
- Citigroup's largest Q2 2022 buy was State Street SPDR MarketAxess Investment Grade 400 Corporate Bond ETF: 250,000 shares worth $24.7M.
- Citigroup added most to Invesco QQQ Trust in Q2 2022, an estimated $628M increase.
- Citigroup's biggest Q2 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $565M.
- Citigroup fully exited People's United Financial Inc in Q2 2022, selling an estimated $103M.
- Citigroup's ten largest holdings make up 29% of its $134B portfolio in Q2 2022.
- Citigroup opened 507 new positions and closed 579 in Q2 2022.
- Citigroup's portfolio value fell 18% quarter-over-quarter to $134B.
Based on Citigroup's 13F filing for Q2 2022, filed 10 Aug 2022.